|
|
Volumn 57, Issue 6, 2001, Pages 547-551
|
|
Use of systemic anti-infective agents in Iran during 1997-1998
|
|
Author keywords
Anti infective utilization; Antibacterial utilization; DUR; Iran
|
|
Indexed keywords
AMOXICILLIN;
AMPICILLIN;
ANTIINFECTIVE AGENT;
BETA LACTAM ANTIBIOTIC;
CARBAPENEM DERIVATIVE;
CEFALEXIN;
CEPHALOSPORIN DERIVATIVE;
CHLORAMPHENICOL;
CIPROFLOXACIN;
CLARITHROMYCIN;
COTRIMOXAZOLE;
DOXYCYCLINE;
ERYTHROMYCIN;
MACROLIDE;
MONOBACTAM DERIVATIVE;
OXYTETRACYCLINE;
PENICILLIN V;
PIVAMPICILLIN;
SULFONAMIDE;
TETRACYCLINE;
TRIMETHOPRIM;
AMINOGLYCOSIDE ANTIBIOTIC AGENT;
ANTIMYCOBACTERIAL AGENT;
CHLORAMPHENICOL DERIVATIVE;
QUINOLONE DERIVATIVE;
ARTICLE;
DENMARK;
DRUG MARKETING;
HEALTH CARE POLICY;
HEALTH SURVEY;
HUMAN;
INFECTION;
IRAN;
METHODOLOGY;
NORWAY;
PRESCRIPTION;
PRIORITY JOURNAL;
SWEDEN;
UTILIZATION REVIEW;
ANALYTIC METHOD;
DRUG UTILIZATION;
AMOXICILLIN;
AMPICILLIN;
ANTI-INFECTIVE AGENTS;
COMMUNICABLE DISEASES;
DATA COLLECTION;
DRUG COSTS;
DRUG UTILIZATION REVIEW;
HUMANS;
IRAN;
TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;
|
|
EID: 0034816268
PISSN: 00316970
EISSN: None
Source Type: Journal
DOI: 10.1007/s002280100351 Document Type: Article |
|
Times cited : (20)
|
|
References (9)
|
